Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/biomarkers-in-alzheimer-s-disease/khan/descriptif_3576023
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3576023

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Biomarkers in Alzheimer's Disease

Langue : Anglais

Auteur :

Couverture de l’ouvrage Biomarkers in Alzheimer's Disease

Biomarkers in Alzheimer?s Disease provides a comprehensive overview of all modalities of Alzheimer?s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer?s disease and technological advancement of biomarkers techniques.

The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer?s disease, and for differential diagnosis of Alzheimer?s disease with other non-Alzheimer?s dementia.

Chapter 1: Introduction to Alzheimer’s Disease Biomarkers

Chapter 2: Clinical Diagnosis of Alzheimer’s Disease

Chapter 3: Neuroimaging Biomarkers in Alzheimer’s Disease

Chapter 4: Genetic Biomarkers in Alzheimer’s Disease

Chapter 5: Alzheimer’s Disease Cerebrospinal Fluid (CSF) Biomarkers

Chapter 6: Peripheral Fluid-Based Biomarkers of Alzheimer’s Disease

Chapter 7: Cell-Based Alzheimer’s Disease Biomarkers

Dr. Khan is an Associate Professor at the Blanchette Rockefeller Neurosciences Institute (BRNI). BRNI is operated in alliance with West Virginia University in Morgantown, USA. Dr. Khan has more than a decade of research experience in the Alzheimer’s disease research area. He is an Associate Editor for Journal of Alzheimer’s Disease and is a regular reviewer for many journals including: European Journal of Pharmaceutical Sciences, Bioorganic & Medicinal Chemistry, CNS & Neurological Disorders-Drug Targets, Neuropeptides, Journal of Biomolecular Structure & Dynamics, Stem Cell Research & Therapy.
  • Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers
  • Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease
  • Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques

Date de parution :

Ouvrage de 276 p.

19x23.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

80,59 €

Ajouter au panier